Nasdaq:US$15.16 (+0.08) | HKEX:HK$23.20 (-0.30) | AIM:£2.26 (+0.01)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Careers
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Careers
News & Press Releases
Hutchmed
News & Presentations
| News & Press Releases
1
2
3
4
5
6
7
8
9
found Documents: 426
Announcements & Press Releases, Oncology / Immunology
| 13 Jul 2009
Phase II Crohn's Disease Trial for HMPL-004 Delivers Encouraging Results
1 item
a090713
Announcements & Press Releases, Group
| 16 Mar 2009
Final Results for the year ended 31 December 2008
1 item
a090316
Announcements & Press Releases, Oncology / Immunology
| 17 Feb 2009
Chi-Med Announces Completion of Patient Enrolment in its US Phase II Crohn's Disease Clinical Trial of HMPL-004, its Lead Anti-Inflammatory Drug Candidate
1 item
a090217
Announcements & Press Releases, Oncology / Immunology
| 8 Jan 2009
HMPL-002 Clinical Update
1 item
a090108
Announcements & Press Releases, Oncology / Immunology
| 23 Dec 2008
Hutchison MediPharma Limited Enters into Drug Discovery and Development Partnership With Ortho-McNeil-Janssen Pharmaceuticals, Inc.
1 item
a081223
Announcements & Press Releases, Oncology / Immunology
| 21 Nov 2008
Chi-Med Expands Drug Discovery and Development Partnership With Lilly
1 item
a081121
Announcements & Press Releases, Oncology / Immunology
| 30 Oct 2008
Hutchison MediPharma wins the 2008 American College of Gastroenterology International Award
1 item
a081030
Announcements & Press Releases, Group
| 6 Aug 2008
Interim Results for the Six Months Ended 30 June 2008
1 item
a080806a
Announcements & Press Releases, Other Ventures
| 23 May 2008
China Healthcare Division Chi-Med increases ownership of its Hutchison Healthcare joint venture
1 item
a080523
Announcements & Press Releases, Other Ventures
| 19 May 2008
Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
1 item
a080519
Announcements & Press Releases, Group
| 19 Mar 2008
Preliminary Results for the year ended 31 December 2007
1 item
a080319
Announcements & Press Releases, Oncology / Immunology
| 29 Feb 2008
Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate
1 item
a080229
Announcements & Press Releases, Other Ventures
| 21 Jan 2008
Strong growth in China Healthcare divisionStreamlining of product range set to further improve financial performance
1 item
a080121
Announcements & Press Releases, Oncology / Immunology
| 22 Nov 2007
Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
1 item
a071122
Announcements & Press Releases, Oncology / Immunology
| 20 Aug 2007
Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
1 item
a070820
Announcements & Press Releases, Group
| 9 Aug 2007
Interim Results for the Six Months Ended 30 June 2007
1 item
a070809
Announcements & Press Releases, Oncology / Immunology
| 2 Jul 2007
Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
1 item
a070702
Announcements & Press Releases, Oncology / Immunology
| 18 Jun 2007
Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
1 item
a070618
Announcements & Press Releases, Oncology / Immunology
| 23 May 2007
Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
1 item
a070523
Announcements & Press Releases, Group
| 21 Mar 2007
Preliminary Results for the year ended 31 December 2006
1 item
a070321
Announcements & Press Releases, Other Ventures
| 17 Jan 2007
Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
1 item
a070117
Announcements & Press Releases, Oncology / Immunology
| 20 Nov 2006
Chi-Med and Merck KGaA Start Collaboration to Discover Novel Small Molecule Anti-Cancer Drugs
1 item
a061120
Announcements & Press Releases, Oncology / Immunology
| 6 Nov 2006
Development Agreement with Procter & Gamble for the Discovery and Development of New Active Ingredients for Beauty Products
1 item
a061106
Announcements & Press Releases, Group
| 9 Aug 2006
Financial Results for the Six Months Ended 30 June 2006
1 item
p060809
Announcements & Press Releases, Group
| 17 Jul 2006
Trading Update
1 item
a060717
Announcements & Press Releases, Oncology / Immunology
| 4 Jul 2006
Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
1 item
a060704
1
2
3
4
5
6
7
8
9